AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Byline: GLORIA LAU
Diabetes afflicts 18.2 million people in the U.S. -- more than 6% of the entire population.
It's the leading cause of new onset blindness, kidney disease and lower limb amputations. And it quadruples your risk of death by heart disease, which is already the country's No. 1 killer. Every year 1.3 million more Americans are diagnosed.
To help combat the disease, several drug makers are in the late stages of studying novel treatments.
Among the promising medicines is Exenatide, an injectable drug that's a chemical copy of a substance found in the saliva of Gila monsters.
Exenatide is the first in a new class of treatments dubbed incretin mimetics.